• Title/Summary/Keyword: Pharmacological profile

Search Result 65, Processing Time 0.021 seconds

General Pharmacology of DWP 305, a New Combined Drug for Hepatic Diseases (간장질환 치료용 의약조성물(DWP 305)의 일반약리작용)

  • 임승욱;염제호;김영만;심점순;박남준;장병수;연제덕;김병오;강진석
    • Biomolecules & Therapeutics
    • /
    • v.2 no.2
    • /
    • pp.173-184
    • /
    • 1994
  • The general and some pharmacological actions of DWP 305 were investigated in animals and the following results were obtained. In central nervous system, DWP 305 had no effects on the pentobarbital induced anaesthesia, locomotor activity, rotarod test, traction test, analgesic action in mice and body temperature in rat. DWP 305 showed no depressive action on convulsion induced by strychnine, electronic shock and pentylenetetrazole. From these results, DWP 305 was considered to have no pharmacological effect on the central nervous system. Furthermore, DWP 305 had no influences on the normal blood pressure and heart rate. In the isolated ileum of guinea pig, DWP 305 inhibited contractive effects against the acetylcholine (10$^{-6}$ g/mι), histamine (10$^{-6}$ g/mι), 5-hydroxytryptamine (10$^{-6}$ g/mι) and BaCl$_2$(10$^{-4}$ g/mι) at a concentration of 2.15$\times$10$^{-4}$ g/ml in bath. In the isolated trachea and vats deference, DWP 305 showed no effect on the contractions produced by histamine and norepinephrine, respectively. DWP 305 showed inhibitory effect on the contractions produced by acetylcholine and oxytocin at a concentration of 2.15$\times$10$^{-4}$ g/ml on the isolated nonpregnant rat uterus. DWP 305 had no effect on the isolated right atrium of guinea pig, bile excretion, urine volume, pH, gastrointestinal motility, gastric secretion and blood aggregation.

  • PDF

General Pharmacology of DWQ-013, A New Synthetic Quinolone Antibiotics (Effects on the Central Nervous System) (신규 합성 퀴놀론계 항생물질(DWQ-013)의 일반 약리 작용 -중추신경계에 대한 작용-)

  • Lim, Seung-Wook;Kim, Young-Man;Yu, Young-Hyo;Lee, Jae-Wook
    • YAKHAK HOEJI
    • /
    • v.38 no.5
    • /
    • pp.586-594
    • /
    • 1994
  • The general pharmacological effects of DWQ-013, a new synthetic quinolone antibacterial agent, were examined on the central nervous system in experimentral animals and the following results were obtained. Drug interaction of DWQ-013 with theophylline, fenbufen and nonsteroidal antiinflammatory drugs was also examined. DWQ-013 decreased touch escape effect on the general behavior and decreased body temperature at a concentration of 1000 mg/kg in mice. But DWQ 013 had no effect on the locomotor activity, rotarod perfomance and traction test in mice. Furthermore, DWQ-013 increased pentobarbital-induced sleeping time and affected the onset time in acetic acid-induced writhing test in mice. DWQ-013 reduced onset time and death time on strychnine-induced convulsions and death time on pentylenetetrazole-induced convulsions at a concentration of 1000 mg/kg in mice. But, the drug had no effect on the electroshock. DWQ-013 did not interact with fenbufen and any other NSAIDs but it did interact with theophylline. From these results, it could be suggested that DWQ-013 had less pharmacological effect than other quinolones on the central nervous system.

  • PDF

General Pharmacology of (R)-JG-381, A New Antidiabetic Agent (항당뇨물질 (R)-JG-381의 일반약리작용)

  • 오우용;이상호;주상섭;박형근;함광수;조장섭;이선미
    • Biomolecules & Therapeutics
    • /
    • v.9 no.1
    • /
    • pp.63-68
    • /
    • 2001
  • General pharmacological properties of (R)-JG-381 were examined in laboratory animals to investigate its safety profile. Administration of (R)-JG-381 (50 and 100 mg/kg) in mice and rats had no effects of general behaviors, central nervous system of the animals in test systems of pentobarbital-induced sleeping time, writhing syndromes induced by 0.7% acetic acid, chemo-shock produced by pentylenetetrazole, and, however, had mild effects on motor coordination. Heart rate and blood pressure were not changed by (R)-JG-381 treatment. (R)-JG-381 also showed mild effects on intestinal propulsion and gastric secretion. These results suggest that (R)-JG-381 dose not exert serious pharmacological effects.

  • PDF

Traditional uses, phytochemistry and pharmacological profile of Bambusa arudinacea Retz

  • Soni, Vishal;Jha, Arvind Kumar;Dwivedi, Jaya;Soni, Priyanka
    • CELLMED
    • /
    • v.3 no.3
    • /
    • pp.20.1-20.6
    • /
    • 2013
  • Bambusa arundinacea family Graminae, is one of the precious plant resources of the earth. It has played a significant role in human civilization since ancient times. It is tall sized tree growing throughout India, moist parts of India. It also occurs in Sri Lanka, Malaya, Peru and Myanmar. The different parts of this plant contain silica, cholin, betain, cynogenetic glycosides, albuminoids, oxalic acid, reducing sugar, resins, waxes, benzoic acid, arginine, cysteine, histidine, niacin, riboflavin, thiamine, protein, gluteline, contains lysine, methionine, betain, cholin, proteolytic enzyme, nuclease, urease. Various parts of this plant such as leaf, root, shoot and seed possess anti-inflammatory, antiulcer, anti-diabetic, anti-oxidant, anthelmintic, antifertility, antibacterial, insectisidal, antiarthritic, vessele protection etc. This review mainly focuses on the traditional, phytochemical and pharmacological information of Bambusa arundinacea.

Novel Heteroaromatic Arylsulfonylimidazolones as Anticancer Agent

  • The, Hung-Dang;Lee, Jee-Hyun;Cho, Soo-Hyun;Hong, Chang-Yong;Jeong, Shin-Wu;Jeon, Ki-Wan;Lee, Sung-Bae;Choi, Whan-Geun;Jung, Sang-Hun
    • Proceedings of the PSK Conference
    • /
    • 2003.04a
    • /
    • pp.233.3-234
    • /
    • 2003
  • Novel arylsulfonylimidazolidinones were previously demonstrated to have broad and highly potent cytotoxicities against a wide range of cancer cell line. Among them 4-phenyl-l N-(p-aminobenzoyl)indoline-5-sulfonyl imidazolidinone (PA) was proved to have good pharmacological profile. Recently modification of indoline moiety of PA led us to find new analogs which show better pharmacological profiles compared to PA. (omitted)

  • PDF

Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases

  • Kim, Jong-Hoon
    • Journal of Ginseng Research
    • /
    • v.42 no.3
    • /
    • pp.264-269
    • /
    • 2018
  • Panax ginseng, also called Asian or Korean ginseng, has long been traditionally used in Korea and China to treat various diseases. The major active ingredients of P. ginseng are ginsenosides, which have been shown to have a variety of therapeutic effects, including antioxidation, anti-inflammatory, vasorelaxation, antiallergic, antidiabetic, and anticancer. To date, approximately 40 ginsenoside components have been reported. Current research is concentrating on using a single ginseng compound, one of the ginsenosides, instead of the total ginseng compounds, to determine the mechanisms of ginseng and ginsenosides. Recent in vitro and in vivo results show that ginseng has beneficial effects on cardiac and vascular diseases through efficacy, including antioxidation, control of vasomotor function, modulation of ion channels and signal transduction, improvement of lipid profiles, adjustment of blood pressure, improvement in cardiac function, and reduction in platelet adhesion. This review aims to provide valuable information on the traditional uses of ginseng and ginsenosides, their therapeutic applications in animal models and humans, and the pharmacological action of ginseng and ginsenosides.

Melissa parviflora Benth. A Review on its Ethnobotany, Phytochemistry and Pharmacological profile

  • Khan, Afshan;Siddiqui, Aisha;Jamal, Anwar
    • CELLMED
    • /
    • v.9 no.4
    • /
    • pp.3.1-3.6
    • /
    • 2019
  • Melissa parviflora Benth. is an aromatic perennial herb of Lamiaceae family. It is one of the most influencial plant and used from centuries in Unani system of medicine for the treatment of various malady such as Epilepsy (mirgi), hemiplegia (falij), migraine (shaqeeqa), insomnia (sehar), indigestion (sue hazm) and palpitation (khafqaan) etc. The Persian physician Avicenna endorsed it for heart problems. It has antitubercular, antipyretic, analgesic and stomachic properties, also used to remove bad breath from mouth, strengthen the gums but its main action is as a tranquillizer and nervine relaxant, it is greatly esteemed for its calming properties. Preliminary performed phytochemical analysis revealed that tannin, flavonoid and saponins are the major components of the plant extract. The plants containing saponins or flavonoids exhibit anticonvulsant activity whereas the flavonoids show various biological activities including antioxidant, anti-inflammatory and cytotoxic-antitumor etc. Keeping in view the tremendous medicinal importance of the plant Badranjboya in Unani Medicine, this review provides updated information on its phytochemistry, therapeutic uses and pharmacological properties.

The Application of Chiral HPLC Columns for Enantiomer Separation of Chiral Drugs (Chiral Drugs의 광학분할을 위한 HPLC Column의 응용)

  • Lee, Won-Jae
    • YAKHAK HOEJI
    • /
    • v.53 no.2
    • /
    • pp.60-68
    • /
    • 2009
  • In terms of chiral issue, two enantiomers of chiral drugs often differ significantly in their pharmacological, toxicological and pharmacokinetic profile. Chiral switches of racemic drugs have been redeveloped as single enantiomers. Several chiral resolution techniques in chirotechnology are introduced and the most used chiral HPLC chromatographic method among several chiral analysis techniques is described with its several advantages. Several types of chiral HPLC columns derived from their chiral selectors are discussed with their property and applications for enantiomer separation.

Synthesis of 4,6-Dichloro-3-[(1-N-Arylaminocarbonyl)-Hydrazono]- 1,3-Dihydro-Indole-2-One as a Potential NMDA Receptor Glycine Site Antagonist

  • Hwang, Ki-Jun;Lee, Tae-Suk
    • Archives of Pharmacal Research
    • /
    • v.23 no.2
    • /
    • pp.112-115
    • /
    • 2000
  • A synthetic procedure for the preparation of indole-2,3-dione derivatives 6 as a potential NMDA receptor glycine site antagonist with improved pharmacological profile compared with 2-carboxyindole derivative 5, starting from readily available 3,5-dichloroaniline (7), is described.

  • PDF